These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10101376)

  • 1. Recent developments in maintenance prescribing and monitoring in the United Kingdom.
    Brewer C
    Bull N Y Acad Med; 1995; 72(2):359-70. PubMed ID: 10101376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction in Bern: from outreach to heroin maintenance.
    Haemmig RB
    Bull N Y Acad Med; 1995; 72(2):371-9. PubMed ID: 10101377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing heroin.
    Carnwath T
    Am J Addict; 2005; 14(4):311-8. PubMed ID: 16188711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
    Morgan O; Griffiths C; Hickman M
    Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 8. Divergent illicit drug policies in Europe.
    Ann Oncol; 1998 Dec; 9(12):1257. PubMed ID: 10232889
    [No Abstract]   [Full Text] [Related]  

  • 9. Injectable methadone prescribing in the United Kingdom--current practice and future policy guidelines.
    Sarfraz A; Alcorn RJ
    Subst Use Misuse; 1999 Oct; 34(12):1709-21. PubMed ID: 10499416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin prescription and history.
    Berridge V
    N Engl J Med; 2009 Aug; 361(8):820-1. PubMed ID: 19692694
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
    Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
    Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.
    Pani PP; Pirastu R; Ricci A; Gessa GL
    Drug Alcohol Depend; 1996 May; 41(1):81-4. PubMed ID: 8793314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team.
    McCusker C; Davies M
    J Subst Abuse Treat; 1996; 13(6):521-31. PubMed ID: 9219151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin maintenance and heroin control.
    Lidz CW
    Int J Addict; 1975; 10(1):35-52. PubMed ID: 1126768
    [No Abstract]   [Full Text] [Related]  

  • 15. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom.
    Metrebian N; Carnwath Z; Mott J; Carnwath T; Stimson GV; Sell L
    Drug Alcohol Rev; 2006 Mar; 25(2):115-21. PubMed ID: 16627300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heroin prescribing debate: integrating science and politics.
    Bammer G; Dobler-Mikola A; Fleming PM; Strang J; Uchtenhagen A
    Science; 1999 May; 284(5418):1277-8. PubMed ID: 10383306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.